dalteparin has been researched along with fibrin in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (21.74) | 18.2507 |
| 2000's | 14 (60.87) | 29.6817 |
| 2010's | 4 (17.39) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Branzi, A; Cervi, V; Magnani, B; Melandri, G; Semprini, F | 1 |
| Agnelli, G; Ascani, A; Morini, M; Nenci, GG; Parise, P | 1 |
| Blombäck, M; Bremme, K; Hellgren, M; Lindberg, H | 1 |
| Abildgaard, U; Dempfle, CE; Kontny, F | 1 |
| Agnelli, G; Baroni, M; D'Angelo, SV; Quintavalla, R; Severi, P; Sonaglia, F | 1 |
| Badimon, JJ; Chesebro, JH; Fuster, V; Rauch, U; Reis, ED; Roqué, M | 1 |
| Chiles, PG; Konopka, R; Marsh, JJ; Morris, TA; Pedersen, CA | 1 |
| Altisent, C; Escolar, G; Galán, AM; Maragall, S; Ordinas, A; Tonda, R | 1 |
| Antovic, A; Blombäck, M; Bremme, K; He, S | 1 |
| Husted, SE; Lassen, JF; Zeuthen, EL | 1 |
| Canbaz, S; Duran, E; Halici, U; Hüseyinova, G; Sunar, H | 1 |
| Armstrong, P; Barnathan, E; Califf, R; James, SK; Siegbahn, A; Simoons, ML; Wallentin, L | 1 |
| Jumper, JM; Lane, RG; MacCumber, MW; McCuen, BW; Nasir, MA | 1 |
| Gram, J; Jespersen, J; Pedersen, RS; Sjøland, JA | 1 |
| Hindman, JW; Keller, JE; Mehall, JR; Smith, SD | 1 |
| Brügger-Andersen, T; Grundt, H; Hetland, Ø; Nilsen, DW; Pönitz, V | 1 |
| Abdollahi, A; Amini, H; Azimi, R; Eslami, Y; Fakhraii, G; Moghimi, S; Zarei, R | 1 |
| Buerke, M; Carter, JM; Hauroeder, B; Maegdefessel, L; Michel, T; Peetz, D; Reindl, I; Schlitt, A; Schubert, S; Werdan, K | 1 |
| Antman, EM; Giraldez, RR; Giugliano, RP; Mohanavelu, S; Morrow, DA; Nicolau, JC; Wiviott, SD | 1 |
| Buerke, M; Busshardt, M; Ebelt, H; Kaeberich, A; Maegdefessel, L; Plehn, A; Raaz, U; Russ, M; Schlitt, A; Schubert, S; Werdan, K | 1 |
| Alvarado, CM; Diaz, JA; Doornbos, NK; Gabriel, JE; Hawley, AE; Henke, PK; Lester, PA; Lowe, SE; Myers, DD; Roelofs, KJ; Schaub, RG; Wakefield, TW; Wrobleski, SK | 1 |
| Abdulghani, S; Gruslin, A; Grynspan, D; Moretti, F | 1 |
| Abdel-Aziz, AH; Abdelbakky, MS; Abdelghany, TM; Ewees, MG | 1 |
10 trial(s) available for dalteparin and fibrin
| Article | Year |
|---|---|
Effects of two dosages of subcutaneous low molecular weight heparin (Parnaparin) and of unfractionated heparin on fibrin formation and lipolysis in acute myocardial infarction.
Topics: Aged; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Female; Fibrin; Heparin; Heparin, Low-Molecular-Weight; Humans; Injections, Subcutaneous; Lipolysis; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time | 1992 |
A pharmacokinetic study of dalteparin (Fragmin) during late pregnancy.
Topics: Adult; Anticoagulants; Antithrombin III; Area Under Curve; Circadian Rhythm; Cross-Over Studies; Dalteparin; Dose-Response Relationship, Drug; Factor Xa; Factor Xa Inhibitors; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Half-Life; Humans; Peptide Fragments; Peptide Hydrolases; Pregnancy; Pregnancy Trimester, Third; Prothrombin; Therapeutic Equivalency; Thrombosis; Time Factors | 1998 |
Fibrin monomer antigen: a novel marker of mortality in acute myocardial infarction.
Topics: Aged; Dalteparin; Double-Blind Method; Female; Fibrin; Fibrinolytic Agents; Humans; Immunoenzyme Techniques; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Risk Assessment | 1999 |
Pre-operative plasma levels of soluble fibrin polymers correlate with the development of deep vein thrombosis after elective neurosurgery.
Topics: Adult; Aged; Biomarkers; Brain Neoplasms; Elective Surgical Procedures; Enoxaparin; Female; Fibrin; Humans; Italy; Male; Middle Aged; Neurosurgical Procedures; Risk Factors; Solubility; Spinal Neoplasms; Venous Thrombosis | 1999 |
Is there a hypercoagulable phase during initiation of antithrombotic therapy with oral anticoagulants in patients with atrial fibrillation?
Topics: Administration, Oral; Aged; Atrial Fibrillation; Biomarkers; Blood Coagulation Factors; Dalteparin; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinolytic Agents; Half-Life; Humans; Male; Middle Aged; Peptide Fragments; Prothrombin; Stroke; Thrombophilia; Time Factors; Vitamin K; Warfarin | 2003 |
Activation of the inflammation, coagulation, and fibrinolysis systems, without influence of abciximab infusion in patients with non-ST-elevation acute coronary syndromes treated with dalteparin: a GUSTO IV substudy.
Topics: Abciximab; Aged; Angina, Unstable; Antibodies, Monoclonal; Anticoagulants; Biomarkers; Blood Coagulation; Blood Coagulation Factors; C-Reactive Protein; Dalteparin; Double-Blind Method; Electrocardiography; Female; Fibrin; Fibrinolysis; Humans; Immunoglobulin Fab Fragments; Inflammation; Interleukin-6; Male; Middle Aged; Platelet Aggregation Inhibitors | 2004 |
Intraperitoneal heparin ameliorates the systemic inflammatory response in PD patients.
Topics: Adult; Aged; C-Reactive Protein; Cross-Over Studies; Double-Blind Method; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Heparin, Low-Molecular-Weight; Humans; Inflammation; Injections, Intraperitoneal; Kidney Failure, Chronic; Male; Middle Aged; Tinzaparin | 2005 |
Inhibition of intraocular fibrin formation after infusion of low-molecular-weight heparin during combined phacoemulsification-trabeculectomy surgery.
Topics: Aged; Cataract; Dalteparin; Double-Blind Method; Female; Fibrin; Fibrinolytic Agents; Glaucoma; Humans; Infusions, Parenteral; Intraocular Pressure; Lens Implantation, Intraocular; Male; Phacoemulsification; Postoperative Complications; Prospective Studies; Trabeculectomy; Visual Acuity | 2006 |
Comparison of bivalirudin, enoxaparin, and unfractionated heparin in preventing cardiac catheter thrombosis. Results of an in-vitro study.
Topics: Anticoagulants; Aspirin; Cardiac Catheterization; Enoxaparin; Eptifibatide; Erythrocytes; Fibrin; Fibrinolytic Agents; Heparin; Hirudins; Humans; In Vitro Techniques; Male; Microscopy, Electron, Scanning; Peptide Fragments; Peptides; Perfusion; Platelet Aggregation Inhibitors; Recombinant Proteins; Thrombosis | 2008 |
Streptokinase and enoxaparin as an alternative to fibrin-specific lytic-based regimens: an ExTRACT-TIMI 25 analysis.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Cohort Studies; Drug Therapy, Combination; Endpoint Determination; Enoxaparin; Female; Fibrin; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Activators; Recombinant Proteins; Streptokinase; Tenecteplase; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Young Adult | 2009 |
13 other study(ies) available for dalteparin and fibrin
| Article | Year |
|---|---|
Effects of low molecular weight heparins on fibrin polymerization and clot sensitivity to t-PA-induced lysis.
Topics: Blood Coagulation; Enoxaparin; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Heparin; Humans; Microscopy, Electron, Scanning; Nadroparin; Nephelometry and Turbidimetry; Polymers; Tissue Plasminogen Activator | 1993 |
Comparative study of antithrombotic effect of a low molecular weight heparin and unfractionated heparin in an ex vivo model of deep arterial injury.
Topics: Adenosine Diphosphate; Animals; Arteries; Blood Coagulation Tests; Blood Flow Velocity; Collagen; Disease Models, Animal; Fibrin; Fibrinogen; Fibrinolytic Agents; Hematologic Tests; Heparin; Heparin, Low-Molecular-Weight; Perfusion; Platelet Aggregation; Platelet Function Tests; Swine; Thrombosis | 2000 |
Anti-thrombotic efficacies of enoxaparin, dalteparin, and unfractionated heparin in venous thrombo-embolism.
Topics: Animals; Antibodies; Anticoagulants; Balloon Occlusion; Dalteparin; Diagnostic Imaging; Disease Models, Animal; Dogs; Drug Evaluation, Preclinical; Enoxaparin; Factor Xa; Factor Xa Inhibitors; Femur; Fibrin; Gamma Rays; Heparin; Heparin, Low-Molecular-Weight; Indium Radioisotopes; Prothrombin; Thromboembolism; Venous Thrombosis | 2000 |
Recombinant factor VIIa (Novoseven) restores deficient coagulation: experience from an ex vivo model.
Topics: Adult; Anticoagulants; Blood Coagulation; Blood Platelets; Coagulants; Dalteparin; Factor VII; Factor VIIa; Fibrin; Hemophilia A; Humans; International Normalized Ratio; Male; Perfusion; Platelet Aggregation; Recombinant Proteins; Stress, Mechanical; Thrombocytopenia | 2001 |
The assay of overall haemostasis potential used to monitor the low molecular mass (weight) heparin, dalteparin, treatment in pregnant women with previous thromboembolism.
Topics: Adult; Anticoagulants; Biomarkers; Blood Coagulation Tests; Dalteparin; Factor Xa Inhibitors; Female; Fibrin; Fibrinolysis; Hemostasis; Humans; Pregnancy; Pregnancy Complications, Hematologic; Risk; Thrombin; Thrombophilia; Venous Thrombosis | 2002 |
The effect of nadroparine on coagulation mechanisms: ultrastructural analysis.
Topics: Animals; Anticoagulants; Blood Coagulation; Blood Platelets; Erythrocytes; Fibrin; Hemostasis; Nadroparin; Rabbits | 2003 |
A prospective, open-label, dose-escalating study of low molecular weight heparin during repeat vitrectomy for PVR and severe diabetic retinopathy.
Topics: Diabetic Retinopathy; Enoxaparin; Female; Fibrin; Fibrinolytic Agents; Humans; Hyphema; Infusion Pumps; Intraoperative Complications; Male; Maximum Tolerated Dose; Middle Aged; Prospective Studies; Reoperation; Vitrectomy; Vitreoretinopathy, Proliferative; Vitreous Hemorrhage | 2005 |
Enoxaparin inhibits fibrin sheath formation and decreases central venous catheter colonization following bacteremic challenge.
Topics: Animals; Anticoagulants; Bacteremia; Catheterization, Central Venous; Catheters, Indwelling; Enoxaparin; Fibrin; Male; Rats; Rats, Sprague-Dawley | 2006 |
The effect of primary percutaneous coronary intervention as compared to tenecteplase on myeloperoxidase, pregnancy-associated plasma protein A, soluble fibrin and D-dimer in acute myocardial infarction.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Enoxaparin; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Peroxidase; Pregnancy; Pregnancy-Associated Plasma Protein-A; Solubility; Tenecteplase; Tissue Plasminogen Activator; Treatment Outcome | 2007 |
The direct thrombin inhibitor argatroban effectively prevents cardiac catheter thrombosis in vitro.
Topics: Anticoagulants; Antithrombin III; Arginine; Blood Coagulation; Blood Platelets; Cardiac Catheterization; Enoxaparin; Factor Xa; Factor Xa Inhibitors; Fibrin; Heparin; Humans; Male; Peptide Hydrolases; Pipecolic Acids; Stress, Mechanical; Sulfonamides; Thrombin; Thrombosis; Time Factors | 2010 |
P-selectin inhibition therapeutically promotes thrombus resolution and prevents vein wall fibrosis better than enoxaparin and an inhibitor to von Willebrand factor.
Topics: Animals; Aptamers, Nucleotide; Blood Coagulation; Collagen; Disease Models, Animal; Enoxaparin; Fibrin; Fibrinolytic Agents; Fibrosis; Iliac Vein; Leukocytes; Magnetic Resonance Angiography; P-Selectin; Papio; Phlebography; Platelet Aggregation; Time Factors; Ultrasonography; Venous Thrombosis; Venous Valves; von Willebrand Factor | 2015 |
Recurrent Massive Perivillous Fibrin Deposition and Chronic Intervillositis Treated With Heparin and Intravenous Immunoglobulin: A Case Report.
Topics: Abortion, Habitual; Abortion, Spontaneous; Adult; Anticoagulants; Aspirin; Chorionic Villi; Dalteparin; Female; Fetal Growth Retardation; Fibrin; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Placenta; Placenta Diseases; Platelet Aggregation Inhibitors; Pregnancy | 2017 |
Enoxaparin prevents fibrin accumulation in liver tissues and attenuates methotrexate-induced liver injury in rats.
Topics: Adaptor Proteins, Signal Transducing; Animals; Anticoagulants; Antirheumatic Agents; Chemical and Drug Induced Liver Injury, Chronic; DNA-Binding Proteins; Enoxaparin; Fibrin; Immunosuppressive Agents; Liver; Male; Methotrexate; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Protective Agents; Rats, Sprague-Dawley | 2019 |